German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Kim Magaly Pabst in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
Search for other papers by Robert Seifert in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Nader Hirmas in
Google Scholar
PubMed
Search for other papers by Martina Broecker-Preuss in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Manuel Weber in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Wolfgang Peter Fendler in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Timo Bartel in
Google Scholar
PubMed
Institute of Pathology, University Hospital Essen, University Duisburg-Essen, Essen, Germany
Search for other papers by Sarah Theurer in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Ken Herrmann in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Rainer Görges in
Google Scholar
PubMed
Brokhin M Omry G Fagin JA Shaha A . Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates
Search for other papers by M L Gild in
Google Scholar
PubMed
Search for other papers by M Bullock in
Google Scholar
PubMed
Search for other papers by C K Pon in
Google Scholar
PubMed
Cancer Genetics Laboratory, Department of Endocrinology, Kolling Institute of Medical Research, Sydney, New South Wales, Australia
Search for other papers by B G Robinson in
Google Scholar
PubMed
Cancer Genetics Laboratory, Department of Endocrinology, Kolling Institute of Medical Research, Sydney, New South Wales, Australia
Search for other papers by R J Clifton-Bligh in
Google Scholar
PubMed
together with cell proliferation. Apoptosis was observed following prolonged treatment with these cell lines. In the PTC cell line, we saw similar growth effects and an NIS-independent increase in uptake of radioactive iodine. Advanced cancers have multiple
Search for other papers by Ulla Schmidt in
Google Scholar
PubMed
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Search for other papers by Ebbe Winther Jensen in
Google Scholar
PubMed
Search for other papers by Jan Kvetny in
Google Scholar
PubMed
Search for other papers by Anne Jarløv in
Google Scholar
PubMed
Endocrine Unit, Department of Medicine, Endocrine Unit, Faculty of Health Sciences, Department of Medicine O, Herlev University Hospital, Herlev Ringvej, DK-2730 Herlev, Denmark
Search for other papers by Jens Faber in
Google Scholar
PubMed
) levels during long-term follow-up after radioactive iodine in multinodular non-toxic goitre . Clinical Endocrinology 1992 37 335 – 337 . ( doi:10.1111/j.1365-2265.1992.tb02334.x ). 12 Knudsen N Faber J Siersbæk-Nielsen K Vadstrup S Sørensen
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Trynke van der Boom in
Google Scholar
PubMed
Search for other papers by Wouter T Zandee in
Google Scholar
PubMed
Search for other papers by Joop D Lefrandt in
Google Scholar
PubMed
of a total thyroidectomy and, if necessary, extensive lymph node dissection, radioactive iodine (RAI) adjuvant therapy, and TSH suppression comparable to the treatment in adults. A nationwide study was performed to evaluate the outcome, surgical
Search for other papers by Joana Simões-Pereira in
Google Scholar
PubMed
Search for other papers by Daniel Macedo in
Google Scholar
PubMed
Search for other papers by Maria João Bugalho in
Google Scholar
PubMed
with lung involvement, CNS metastases can cause acute disabling symptoms and a marked reduction of patients’ survival. International guidelines ( 13 ) recommend surgical resection of CNS metastases regardless of its radioactive iodine (RAI) avidity
Search for other papers by Hyunjae Lee in
Google Scholar
PubMed
Search for other papers by Tae-Shin Kim in
Google Scholar
PubMed
Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
Search for other papers by Ja-Yoon Gu in
Google Scholar
PubMed
Search for other papers by Mi Ran Yu in
Google Scholar
PubMed
Search for other papers by Seung-Eun Lee in
Google Scholar
PubMed
Search for other papers by Eun Sook Kim in
Google Scholar
PubMed
Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
Search for other papers by Hyun Kyung Kim in
Google Scholar
PubMed
greatest prevalence in both groups, followed by stage II. The proportion of patients who received postoperative radioactive iodine therapy did not significantly differ between two groups. Table 1 Clinicopathologic characteristics of 122 patients with
Search for other papers by Pan Chen in
Google Scholar
PubMed
Search for other papers by Liqin Pan in
Google Scholar
PubMed
Search for other papers by Wensi Huang in
Google Scholar
PubMed
Search for other papers by Huijuan Feng in
Google Scholar
PubMed
Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Search for other papers by Juqing Wu in
Google Scholar
PubMed
Search for other papers by Jing Wang in
Google Scholar
PubMed
Search for other papers by Yuying Deng in
Google Scholar
PubMed
Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
Search for other papers by Yanying Chen in
Google Scholar
PubMed
Hospital of Southern Medical University. We obtained informed consent from each patient after a full explanation of the purpose and nature of all study procedures. Our department is the center of radioactive iodine ( 131 I) treatment of thyroid cancer in
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel
Search for other papers by Elena Izkhakov in
Google Scholar
PubMed
Community Division, Clalit Health Services, Tel Aviv, Israel
The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel
Search for other papers by Joseph Meyerovitch in
Google Scholar
PubMed
Search for other papers by Micha Barchana in
Google Scholar
PubMed
Department of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Search for other papers by Yacov Shacham in
Google Scholar
PubMed
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for other papers by Naftali Stern in
Google Scholar
PubMed
National Cancer Registry, Israel Center for Disease Control, Ministry of Health, Israel, Ramat Gan, Israel
Search for other papers by Lital Keinan-Boker in
Google Scholar
PubMed
Sanal B Isik İ Kormaz M Kucur C Can F Kilit TP Kahraman C Kacar E Kocak A . Effect of radioactive iodine therapy on carotid intima media thickness in patients with hyperthyroidism . Annals of Nuclear Medicine 2016 30 75 – 80 . ( https
European Institute for Molecular Imaging (EIMI), University of Münster, Münster, Germany
Search for other papers by Daniel Alexander Hescheler in
Google Scholar
PubMed
Search for other papers by Milan Janis Michael Hartmann in
Google Scholar
PubMed
Search for other papers by Burkhard Riemann in
Google Scholar
PubMed
Search for other papers by Maximilian Michel in
Google Scholar
PubMed
Search for other papers by Christiane Josephine Bruns in
Google Scholar
PubMed
Search for other papers by Hakan Alakus in
Google Scholar
PubMed
Search for other papers by Costanza Chiapponi in
Google Scholar
PubMed
, radioactive iodine; SD, stable disease; TKI, tyrosine kinase inhibitor; RET, rearranged during transfection; VEGFR, vascular endothelial growth factor receptor. However, ATC is an orphan disease, accounting for only 3% of thyroid cancers ( 1 ). Given
Clinic for Nuclear Medicine, University Hospital of Zürich, Zürich, Switzerland
Search for other papers by Luca Giovanella in
Google Scholar
PubMed
Search for other papers by Maria Luisa Garo in
Google Scholar
PubMed
Search for other papers by Domenico Albano in
Google Scholar
PubMed
Search for other papers by Rainer Görges in
Google Scholar
PubMed
Faculty of Biomedical Sciences, Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland
Search for other papers by Luca Ceriani in
Google Scholar
PubMed
-Thu H Taketomi-Takahashi A Hirasawa H Tsushima Y . Early detection of progressive disease using thyroglobulin doubling-time in metastatic differentiated thyroid carcinoma treated with radioactive iodine . Nuclear Medicine Communications 2020 41